In all stages, as well as stages I–II and stage III, simultaneous consideration of all leukocyte subtypes combined slightly outperformed exclusive consideration of CD4+ T cell proportions for prediction of CRC prognosis. Here, CD4 is linked to colorectal carcinoma.